FDA Brief

Warning letters Drugs

FDA warning letter to

Healthy Living Clinic

LowIssued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

FDA warned Healthy Living Clinic that its website misbrands compounded semaglutide by comparing it to Wegovy, Ozempic, and Rybelsus.

What happened

In August 2025, FDA reviewed the website https://healthyliving.clinic and found it offered compounded drug products, including semaglutide. FDA said the website claim “It is also available under brand names like Wegovy, Ozempic, and Rybelsus” falsely implies the compounded products are the same as FDA-approved drugs. FDA called the claim false or misleading and the products misbranded.

What FDA found

  1. FDA says the website claim is false or misleading labeling for a drug, which misbrands it.

    FDCA § 502(a) [21 U.S.C. § 352(a)]
  2. FDA says the same claim in advertising or promotion of a compounded drug is false or misleading, which misbrands it.

    FDCA § 502(bb) [21 U.S.C. § 352(bb)]
  3. FDA says introducing or delivering these misbranded drugs into interstate commerce is prohibited.

    FDCA § 301(a) [21 U.S.C. § 331(a)]
  4. FDA says receiving or delivering misbranded drugs in interstate commerce is also prohibited.

    FDCA § 301(c) [21 U.S.C. § 331(c)]

What FDA wants

FDA tells the company to take immediate action, including ceasing the misleading claim, and to send OCQC/CDER a written response within 15 working days of receipt. The response must describe steps taken, how recurrence will be prevented, and include related documents; if the company disagrees, it must give reasoning and support.

Who should pay attention

  • telehealth companies selling compounded semaglutide
  • compounding pharmacies and clinics marketing compounded GLP-1 drugs
  • online drug sellers making brand-name comparisons

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low